Clinical trials
Anxiety Disorders trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 16 |
| 2024 | 9 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Unknown status | 14 |
| Recruiting | 10 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Erasmus Medical Center | 15 |
| Tilburg University | 5 |
| Radboud University Medical Center | 4 |
| VU University of Amsterdam | 3 |
| Amsterdam UMC, location VUmc | 2 |
| Elisabeth-TweeSteden Ziekenhuis | 2 |
| Erasmus University Rotterdam | 2 |
| GGZ Noord-Holland-Noord | 2 |
| Leiden University Medical Center | 2 |
| ProPersona | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 69 |
| Depressive Disorder | 4 |
| Fatigue | 4 |
| Obsessive-Compulsive Disorder | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| Brain Neoplasms | 3 |
| Rumination Syndrome | 3 |
| Generalized Anxiety Disorder | 2 |
| Major Depressive Disorder | 2 |
| Mood Disorders | 2 |
Trials
Showing 51 to 69 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.